Heron Therapeutics Inc Shares Near 52-Week Low - Market Mover
The shares closed 1.3% above its 52-week low of $9.03, with trading volume higher than its 30 day average
Nov 30, 2021 by Kwhen Finance Editors
Heron Therapeutics Inc (HRTX) shares closed today at 1.3% above its 52 week low of $9.03, giving the company a market cap of $932M. The stock is currently down 56.8% year-to-date, down 49.1% over the past 12 months, and down 38.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%.
Trading Activity
- Trading volume this week was 10.3% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Heron Therapeutics Inc | -2.8 | -56.8 | -49.1 | ||
| Dow Jones Industrial Average | 0.6 | 16.6 | 19.4 | -3.4 | 21.0 |
| S&P 500 Index | 1.2 | 25.5 | 29.6 | -2.0 | 29.6 |
| Health Care | 0.1 | 16.3 | 21.2 | -3.3 | 21.0 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 1092.1%
- The company's stock price performance over the past 12 months lags the peer average by -1507.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | HRTX | 0 | -56.8 | -49.1 | ||
| Peer Avg | N/A | 69.7 | -4.8 | 3.5 | ||
| Alkermes plc | ALKS | -39.5 | 12.3 | 21.1 | ||
| Ligand Pharmaceuticals, Inc. - Class B | LGND | 38.0 | 56.1 | 80.7 | ||
| Pacira BioSciences Inc | PCRX | 36.9 | -14.6 | -19.9 | ||
| Nektar Therapeutics | NKTR | -4.1 | -34.6 | -33.8 | ||
| Surmodics, Inc. | SRDX | 396.4 | 3.5 | 17.4 | ||
| Durect Corp | DRRX | -9.2 | -51.2 | -44.5 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: